Cargando…

Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor

Breast metastases are uncommon findings compared to primary breast cancer and in particular bilateral secondary breast lesions from neuroendocrine tumor (NET)s are extremely rare with just less over 13 cases described in literature. We reported herewith the case of a 54-year-old woman who presented...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassallo, Lorenzo, Fasciano, Mirella, Ortoleva, Grazia, Armando, Enrico, Marchisio, Federica Groppo, Russo, Lucianna, Zavattero, Carla Angela, Lingua, Gisella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551534/
https://www.ncbi.nlm.nih.gov/pubmed/34745398
http://dx.doi.org/10.1016/j.radcr.2021.09.008
_version_ 1784591179430494208
author Vassallo, Lorenzo
Fasciano, Mirella
Ortoleva, Grazia
Armando, Enrico
Marchisio, Federica Groppo
Russo, Lucianna
Zavattero, Carla Angela
Lingua, Gisella
author_facet Vassallo, Lorenzo
Fasciano, Mirella
Ortoleva, Grazia
Armando, Enrico
Marchisio, Federica Groppo
Russo, Lucianna
Zavattero, Carla Angela
Lingua, Gisella
author_sort Vassallo, Lorenzo
collection PubMed
description Breast metastases are uncommon findings compared to primary breast cancer and in particular bilateral secondary breast lesions from neuroendocrine tumor (NET)s are extremely rare with just less over 13 cases described in literature. We reported herewith the case of a 54-year-old woman who presented to our Breast Unit after noticing multiple, mobile, bilateral breast lumps. Imaging studies confirmed the presence of multiple, circumscribed, bilateral breast masses with slightly spiculated margins, classified as suspicious for malignancy (BI-RADS 4). A tru-cut biopsy was carried out on the largest lesion of each side and histopathologic and immunohistochemistry examination was consistent with metastases from pancreatic neuroendocrine tumor (PNET). Total-body CT revealed the presence of a mass located in the pancreatic body - tail with associated abdominal lymphadenopathies and multiple secondary nodules in bilateral breast and in the liver. Stage IV disease was diagnosed, patient did not undergo surgery and started LAR – octreotide therapy. Although rare, breast metastases from NETs represent an important diagnostic challenge for practitioners because of the difficulty to differentiate from a primary breast carcinoma or even from benign breast lesions. Clinicians should be aware of the possibility of bilateral breast metastases in differential diagnosis of breast lesions in order to ensure the correct diagnosis and the most appropriate management of these patients.
format Online
Article
Text
id pubmed-8551534
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85515342021-11-04 Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor Vassallo, Lorenzo Fasciano, Mirella Ortoleva, Grazia Armando, Enrico Marchisio, Federica Groppo Russo, Lucianna Zavattero, Carla Angela Lingua, Gisella Radiol Case Rep Case Report Breast metastases are uncommon findings compared to primary breast cancer and in particular bilateral secondary breast lesions from neuroendocrine tumor (NET)s are extremely rare with just less over 13 cases described in literature. We reported herewith the case of a 54-year-old woman who presented to our Breast Unit after noticing multiple, mobile, bilateral breast lumps. Imaging studies confirmed the presence of multiple, circumscribed, bilateral breast masses with slightly spiculated margins, classified as suspicious for malignancy (BI-RADS 4). A tru-cut biopsy was carried out on the largest lesion of each side and histopathologic and immunohistochemistry examination was consistent with metastases from pancreatic neuroendocrine tumor (PNET). Total-body CT revealed the presence of a mass located in the pancreatic body - tail with associated abdominal lymphadenopathies and multiple secondary nodules in bilateral breast and in the liver. Stage IV disease was diagnosed, patient did not undergo surgery and started LAR – octreotide therapy. Although rare, breast metastases from NETs represent an important diagnostic challenge for practitioners because of the difficulty to differentiate from a primary breast carcinoma or even from benign breast lesions. Clinicians should be aware of the possibility of bilateral breast metastases in differential diagnosis of breast lesions in order to ensure the correct diagnosis and the most appropriate management of these patients. Elsevier 2021-10-07 /pmc/articles/PMC8551534/ /pubmed/34745398 http://dx.doi.org/10.1016/j.radcr.2021.09.008 Text en © 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Vassallo, Lorenzo
Fasciano, Mirella
Ortoleva, Grazia
Armando, Enrico
Marchisio, Federica Groppo
Russo, Lucianna
Zavattero, Carla Angela
Lingua, Gisella
Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor
title Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor
title_full Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor
title_fullStr Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor
title_full_unstemmed Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor
title_short Bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor
title_sort bilateral breast metastases as the first manifestation of an occult pancreatic neuroendocrine tumor
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551534/
https://www.ncbi.nlm.nih.gov/pubmed/34745398
http://dx.doi.org/10.1016/j.radcr.2021.09.008
work_keys_str_mv AT vassallolorenzo bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor
AT fascianomirella bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor
AT ortolevagrazia bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor
AT armandoenrico bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor
AT marchisiofedericagroppo bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor
AT russolucianna bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor
AT zavatterocarlaangela bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor
AT linguagisella bilateralbreastmetastasesasthefirstmanifestationofanoccultpancreaticneuroendocrinetumor